IL209869A0 - Iqgap3 epitope peptides and vaccines containing the same - Google Patents

Iqgap3 epitope peptides and vaccines containing the same

Info

Publication number
IL209869A0
IL209869A0 IL209869A IL20986910A IL209869A0 IL 209869 A0 IL209869 A0 IL 209869A0 IL 209869 A IL209869 A IL 209869A IL 20986910 A IL20986910 A IL 20986910A IL 209869 A0 IL209869 A0 IL 209869A0
Authority
IL
Israel
Prior art keywords
iqgap3
same
epitope peptides
vaccines containing
vaccines
Prior art date
Application number
IL209869A
Other languages
English (en)
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of IL209869A0 publication Critical patent/IL209869A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C07K14/4706—Guanosine triphosphatase activating protein, GAP
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL209869A 2008-06-11 2010-12-09 Iqgap3 epitope peptides and vaccines containing the same IL209869A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6053808P 2008-06-11 2008-06-11
PCT/JP2009/002613 WO2009150835A1 (en) 2008-06-11 2009-06-10 Iqgap3 epitope peptides and vaccines containing the same

Publications (1)

Publication Number Publication Date
IL209869A0 true IL209869A0 (en) 2011-02-28

Family

ID=41416549

Family Applications (1)

Application Number Title Priority Date Filing Date
IL209869A IL209869A0 (en) 2008-06-11 2010-12-09 Iqgap3 epitope peptides and vaccines containing the same

Country Status (13)

Country Link
US (1) US20110200626A1 (enExample)
EP (1) EP2303909A4 (enExample)
JP (1) JP2011523937A (enExample)
KR (1) KR20110036903A (enExample)
CN (1) CN102119169A (enExample)
AU (1) AU2009258788A1 (enExample)
BR (1) BRPI0915527A2 (enExample)
CA (1) CA2727485A1 (enExample)
IL (1) IL209869A0 (enExample)
MX (1) MX2010013680A (enExample)
RU (1) RU2010154081A (enExample)
TW (1) TW201000115A (enExample)
WO (1) WO2009150835A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI580431B (zh) 2008-08-19 2017-05-01 腫瘤療法 科學股份有限公司 Ｈｉｇ２與ｕｒｌｃ１０抗原決定位胜肽以及含此胜肽之疫苗
TW201134480A (en) * 2010-04-08 2011-10-16 Oncotherapy Science Inc CLUAP1 peptides and vaccines including the same
GB201515321D0 (en) 2015-08-28 2015-10-14 Immatics Biotechnologies Gmbh Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
TWI796642B (zh) 2015-08-28 2023-03-21 德商英麥提克生物技術股份有限公司 用於多種癌症之免疫治療的新穎胜肽、胜肽的組合物及支架
GB201520542D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520568D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd Peptides
GB201520550D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
KR102292655B1 (ko) 2017-04-26 2021-08-23 지브이에스 필트레이션, 인코포레이티드 다중 비드 에어 필터 씰
CN112521455B (zh) * 2020-12-08 2022-09-02 长春理工大学 一种检测膀胱癌抗原蛋白特异性的多肽及其应用
CN118930633A (zh) * 2023-05-12 2024-11-12 中国科学院深圳先进技术研究院 肿瘤相关抗原表位肽及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001064835A2 (en) * 2000-02-28 2001-09-07 Hyseq, Inc. Novel nucleic acids and polypeptides
DE102004026135A1 (de) * 2004-05-25 2006-01-05 Immatics Biotechnologies Gmbh An MHC-Moleküle bindende Tumor-assoziierte Peptide
JP5109131B2 (ja) * 2005-02-10 2012-12-26 オンコセラピー・サイエンス株式会社 膀胱癌を診断する方法
EP2305811A1 (en) * 2005-07-27 2011-04-06 Oncotherapy Science, Inc. Method of diagnosing smal cell lung cancer
EP2311986B1 (en) * 2005-07-27 2015-04-15 Oncotherapy Science, Inc. Method of diagnosing esophageal cancer

Also Published As

Publication number Publication date
CA2727485A1 (en) 2009-12-17
BRPI0915527A2 (pt) 2016-01-26
JP2011523937A (ja) 2011-08-25
US20110200626A1 (en) 2011-08-18
EP2303909A1 (en) 2011-04-06
TW201000115A (en) 2010-01-01
MX2010013680A (es) 2011-02-23
AU2009258788A1 (en) 2009-12-17
KR20110036903A (ko) 2011-04-12
WO2009150835A1 (en) 2009-12-17
RU2010154081A (ru) 2012-07-20
EP2303909A4 (en) 2012-10-31
CN102119169A (zh) 2011-07-06

Similar Documents

Publication Publication Date Title
IL211131A0 (en) Inhbb epitope and vaccines containing the same
IL209967A0 (en) Cdca1 epitope peptides and vaccines containing the same
IL209869A0 (en) Iqgap3 epitope peptides and vaccines containing the same
IL220752A0 (en) Tem8 peptides and vaccines comprising the same
IL211117A0 (en) Hig2 and urlc10 epitope peptide and vaccines containing the same
SG173751A1 (en) Foxm1 peptides and vaccines containing the same
IL209870A0 (en) Mybl2 epitope peptides and vaccines containing the same
IL229926A0 (en) 3neil peptides and vaccines containing them
IL210861A0 (en) Melk epitope peptides and vaccines containing the same
ZA201103667B (en) Rab6kifl/kif20a epitope peptide and vaccines containing the same
IL216211A0 (en) Cdc45l peptides and vaccines including the same
ZA201303886B (en) Tomm34 peptides and vaccines including the same
IL213318A0 (en) C1orf59 peptides and vaccines including the same
IL214453A0 (en) Vangli peptides and vaccines including the same
IL215268A0 (en) C6orf167 peptides and vaccines containing the same
IL219927A0 (en) Mybl2 peptides and vaccines containing the same
IL220146A0 (en) Tmem22 peptides and vaccines including the same
IL221474A0 (en) Hjurp peptides and vaccines including the same
ZA201104890B (en) Wdrpuh epitope peptides and vaccines containing the same
IL225552A0 (en) wdhd1 peptides and vaccines containing them
IL225553A0 (en) 54orf18c peptides and vaccines containing them
HK1155755A (en) Iqgap3 epitope peptides and vaccines containing the same
HK1162528A (en) Wdrpuh epitope peptides and vaccines containing the same
HK1166088A (zh) C6orf167肽及包含它的疫苗
HK1157815A (en) Inhbb epitope peptides and vaccines containing the same